Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-23T20:58:53.101Z Has data issue: false hasContentIssue false

Impact of comorbidity on health-related quality of life among type 2 diabetic patients in primary care

Published online by Cambridge University Press:  06 April 2020

Sandipana Pati*
Affiliation:
Centre for Chronic Conditions and Injuries, Public Health Foundation of India, New Delhi, India Indian Institute of Public Health Bhubaneswar, Bhubaneswar, Odisha, India
Sanghamitra Pati
Affiliation:
Department of Health Research, Indian Council of Medical Research Regional Medical Research Centre, Bhubaneswar, Odisha, India
Marjan van den Akker
Affiliation:
Institute of General Practice, Johann Wolfgang Goethe University, Frankfurt am Main, Germany Department of Family Medicine, Maastricht University, Maastricht, The Netherlands Academic Centre of General Practice, KU Leuven, Leuven, Belgium
F. (François) G. Schellevis
Affiliation:
Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers location VUmc, Amsterdam, The Netherlands NIVEL (Netherlands Institute for Health Services Research), Utrecht, The Netherlands
Sunita Jena
Affiliation:
Department of Public Health, Utkal University, Bhubaneswar, Odisha, India
Jako S. Burgers
Affiliation:
Department of Family Medicine, School CAPHRI, Maastricht University, Maastricht, The Netherlands Dutch College of General Practitioners, Utrecht, The Netherlands
*
Author for correspondence: Dr Sandipana Pati, Indian Institute of Public Health Bhubaneswar, Plot No. 267/3408, Jaydev Vihar, Mayfair Lagoon Road, Bhubaneswar, 751013Odisha, India. E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background:

Health-related quality of life (HRQL) is an important outcome for chronic diseases such as diabetes mellitus that is associated with complications, comorbidities, and lifelong care.

Objectives:

The present study aims to explore the impact of comorbidities on the different dimensions of HRQL among type 2 diabetic patients attending primary care.

Methods:

A total of 912 type 2 diabetic patients attending primary care centers in India were assessed using a predesigned and pretested questionnaire – Diabetes Comorbidity Evaluation Tool in Primary Care. The HRQL was measured by physical and mental health summary scores [physical component summary (PCS) and mental component summary (MCS)] of the Short Form Health Survey 12. The associations of sociodemographic variables and clinical variables with PCS and MCS were assessed, and a minimal difference of 5 in the scores (on a scale of 0–100) was kept as clinically relevant difference for this study. Mean differences in mental (MCS) and physical (PCS) scores of quality of life by number and type of comorbid conditions in type 2 diabetic patients were calculated.

Result:

The presence of comorbid conditions was associated with lower scores of PCS and MCS (P < 0.001). Significant reduction in HRQL was found with increase in number of comorbid conditions, and negative association was established between the number of comorbidities and the PCS (r = −0.25, P < 0.0001) and MCS scores (r = −0.21, P < 0.0001). Among comorbidities, acid peptic disease, chronic lung disease, visual impairment, depression, and stroke had significantly and clinically relevant reduced scores. Duration of diabetes, use of insulin, and obesity were also associated with poor HRQL.

Conclusion:

Comorbidities considerably impair the HRQL among type 2 diabetic patients. National programs designed for diabetes management should also take into account the challenges of coexisting chronic conditions and its substantial effect on HRQL.

Type
Research
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s) 2020

Introduction

Health-related quality of life (HRQL) is a societal relevant measure to assess the outcomes of clinical trials and quality of care. It acts as a valuable add-on in guiding medical treatment and research, particularly in patients with chronic diseases. Studies around the globe demonstrated that chronic conditions and multimorbidity are associated with poor HRQL (Reference Fortin, Bravo, Hudon, Lapointe, Almirall, Dubois and VanasseFortin et al., 2006; Agborsangaya et al., Reference Agborsangaya, Lau, Lahtinen, Cooke and Johnson2013). Among chronic diseases, diabetes mellitus is one of the most frequent chronic and debilitating diseases that demands prolonged medication use and lifestyle changes. Diabetes is associated with low HRQL in comparison to people without chronic conditions (Néss et al., Reference Néss, Midthjell, Moum, Sørensen and Tambs1995; Rubin and Peyrot, Reference Rubin and Peyrot1999). Sprangers et al. (Reference Sprangers, de Regt, Andries, van Agt, Bijl, de Boer, Foets, Hoeymans, Jacobs, Kempen and Miedema2000) concluded that quality of life among people with diabetes is comparable to people with other chronic conditions such as cardiovascular disease, cancer, visual impairment, or chronic respiratory disease. Low HRQL affects diabetes management and control, and poor glycemic control affects HRQL making it a vicious circle. The associated complications and comorbidities further affect the HRQL among diabetic patients. Adriaanse et al. (Reference Adriaanse, Drewes, van der Heide, Struijs and Baan2016) found a high prevalence of comorbidities among type 2 diabetes mellitus (T2DM) patients in the Netherlands and its considerable impact on quality of life. Wee et al. (Reference Wee, Cheung, Li, Fong and Thumboo2005) concluded from a multiethnic, population-based study that coexisting chronic conditions have an additive effect on lowering of HRQL among diabetic patients. Wexler et al. (Reference Wexler, Grant, Wittenberg, Bosch, Cagliero, Delahanty, Blais and Meigs2006) also found that chronic complications of diabetes are associated with decreased HRQL. However, there is paucity of studies exploring the impact of multiple comorbidities on the physical and mental components of quality of life. Furthermore, the burden of diabetes is assumed to be higher in low- and middle-income countries (LMICs). Studies conducted in these countries, however, only focused on prevalence of comorbidities or on the effect of chronic complications on quality of life (Javanbakht et al., Reference Javanbakht, Abolhasani, Mashayekhi and Baradaran2012; Shim et al., Reference Shim, Lee, Toh, Tang and Ko2012; Patel et al., Reference Patel, Oza, Patel, Malhotra and Patel2014; Saleh et al., Reference Saleh, Ara, Mumu and Hafez2015). The present study aims to assess the impact of the number and type of comorbid conditions on HRQL among type 2 diabetic patients attending inner-city primary care facilities in Bhubaneswar, India.

Methods

Study design and setting

A cross-sectional interview survey was conducted in all 17 urban primary health care centers in Bhubaneswar, the capital city of Odisha (India) with a population of 900 000 inhabitants (Anon, 2015). According to the National Sample Survey Office’s 71st round on social consumption of health, about 72% of outpatient care in Odisha is provided by public health care professionals (Sundararaman et al., Reference Sundararaman, Muraleedharan and Mukhopadhyay2016). The public health care system has a three-tier structure comprising of primary, secondary, and tertiary levels. Primary health care centers are involved in delivering primary care, while district hospitals and sub-divisional hospitals render secondary care. Tertiary health care is provided by medical college hospitals.

Study participants

Patients attending a primary health care center between September 2014 and February 2015, who had been diagnosed by a physician with T2DM for more than 6 months according to their personal medical record, were eligible to be included in the study. Minimum sample size required was estimated to be 942. This was based on prior studies (Struijs et al., Reference Struijs, Baan, Schellevis, Westert and Van Den Bos2006) of an expected prevalence of 40% [confidence interval (CI) = 95%], an α value of 0.05 and power at 0.8, with confidence levels set at 95%, and a non-response rate of 10%.

Sampling

A multistage sampling design was used. All the public primary health care facilities in the city of Bhubaneswar were included in the study. The calculated required sample size was divided between these 17 centers based on the proportional allocation method, weighted depending on the average outpatient attendance of the past 6 months. Owing to limited consultation time in the health care centers, and only one interviewer being available per center, and each interview duration being 20–30 min, for the feasibility of the study every third eligible T2DM patient was invited. Patients too ill to participate or with emergency health conditions were excluded from the study. Anonymized details of all patients who refused to participate (age, gender, reason for exclusion) were recorded to compare the characteristics of the participants with the nonparticipants.

Measurements

Participating patients were interviewed in a separate private chamber using a predesigned and pretested questionnaire Diabetes Comorbidity Evaluation Tool in Primary Care (DCET-PC). The DCET-PC is derived from the ‘Multimorbidity Assessment Questionnaire for Primary Care’, a validated questionnaire, which was pretested and adapted for our study according to the feedback from pretesting (Pati et al., Reference Pati, Hussain, Swain, Salisbury, Metsemakers, Knottnerus and Akker2016). Two graduate nurses trained in patient history taking and interview techniques carried out the interviews, and 10% of the interviews were carried out in the presence of the first author. The DCET-PC (Supplementary Material) included questions on sociodemographic variables, that is, age, sex, socioeconomic status (above poverty line, below poverty line), educational level (no education, primary level, secondary, graduate, and above), employment status (employed, unemployed, homemaker, retired), and clinical variables (Kung et al., Reference Kung, Janus and Lau1996; Janus et al., Reference Janus, Wat, Lam, Cockram, Siu, Liu and Lam2000; Shim et al., Reference Shim, Lee, Toh, Tang and Ko2012) such as the existence of comorbid conditions, eliciting information on whether the patient had any of the 15 listed chronic conditions other than diabetes and obesity [defined as body mass index (BMI) >25, collected by anthropometry measurement], duration of diabetes (IASO, 2000), and type of diabetes treatment (oral medication, insulin use). The details of development and domains of the DCET-PC questionnaire are described in our previous paper (Pati and Schellevis, Reference Pati and Schellevis2017).

Health-related quality of life

HRQL was measured using the Short Form Health Survey 12 (SF-12), which is a shorter version of the 36-item SF-36 Health Survey. This includes the measurement of physical functioning, role physical, role emotional, bodily pain, general health, vitality, social functioning, and mental health (MH). The eight domain scores were combined into the SF-12 physical component summary (PCS-12) and mental component summary (MCS-12) scores. The summary scores of PCS and MCS, which were derived by the weighted sum of 12-item scores using the US standard SF-12 scoring algorithm, were considered as the principal outcomes of this study (Ware et al., Reference Ware, Keller and Kosinski1995; Lam et al., Reference Lam, Eileen and Gandek2005).

Statistical analysis

Characteristics of the study samples are described using means and SDs, or proportions and 95% CIs, where appropriate. Descriptive statistics were performed with HRQL and clinical characteristics. Differences in study sample characteristics for patients with and without comorbidities were examined using t-tests for continuous variables and chi-square tests for dichotomous and categorical variables. The associations of sociodemographic variables and clinical variables with PCS and MCS were assessed, and a minimal score difference of 5 (on a scale of 0–100) was kept as a clinically relevant difference for this study. Pearson’s correlations test was performed in order to assess the linear relationship and strength of association between the number of comorbidities and quality of life. To analyze both parameters, we adjusted for variables such as age, sex, duration of diabetes, BMI, and insulin use and calculated the unadjusted and adjusted β coefficients for MCS and PCS scores by number of comorbid conditions [0 (reference category), 1, 2, 3, and 4 or more] among T2DM patients. Additionally, we performed analysis of variance to test the differences in unadjusted and adjusted mean PCS and MCS scores by number of comorbid chronic conditions. Furthermore, mean differences in mental (MCS) and physical (PCS) scores of quality of life by comorbid chronic condition in type 2 diabetic patients were calculated. Statistical analyses were performed using STATA V12 (Stata Crop V12, Texas, USA).

Ethical considerations

Respondents were informed about the purpose of the study and the information assessed. We collected their signature or thumb impression on the informed consent form. The data were coded and the identities of the respondents were kept confidential. The Odisha state research and ethics committee gave the ethical approval for the study (letter no. 161/SHRMU dt. 16.05.2014).

Results

A total of 942 T2DM patients were approached with a response rate of 97% (n = 912). The age group of 50–59 years (34.5%) was the largest, and the mean age of respondents was 55.3 (SD: 10.3) years. Most participants were male (63.1%), had university education (40.2%), and were living below poverty line (63.3%). The overall PCS (mean ± SD) was 32.8 ± 13.7 and the overall MCS (mean ± SD) was 45.9 ± 9.0. The characteristics of study participants are summarized in Table 1.

Table 1. Basic characteristics of type 2 diabetic patients by comorbidity status

CI = confidence interval; SF-12 = F-Short Form Health Survey 12; PCS-12 = physical component summary 12; MCS-12 = mental component summary 12.

Prevalence of comorbidities

The mean number of comorbidities was 1.8 (SD: 0.4). Among the participants, 84% had any comorbidity, and the majority of participants had a single (29%) comorbidity, followed by 25% with two, 17% with three, and 14% with four or more comorbidities. Female patients reported more comorbidities than male patients (Figure 1). The most frequent comorbid conditions among participants were hypertension (62%), followed by acid peptic disease (APD; 27%), chronic back ache (21%), and arthritis (21%) (Figure 2).

Figure 1. Number of comorbidities across sex.

Figure 2. Chronic comorbidities.

Quality of life related to number of comorbid conditions

As the number of comorbidities increased, the mean difference in PCS and MCS unadjusted and adjusted scores significantly increased, indicating lower physical and mental HRQL. These effects were most pronounced for the PCS. The unadjusted and adjusted PCS mean score differences increased to −11.2 and −9.8, respectively, for diabetic patients with four or more comorbid conditions compared to patients without comorbid conditions (Table 2). The mean score decreased in both PCS and MCS as the number of comorbid conditions increased. Additional Pearson’s correlations confirmed the negative association between the number of comorbidities and the PCS (r = −0.25, P < 0.0001) and MCS scores (r = −0.21, P < 0.0001)

Table 2. Mean scores with SD, unadjusted and adjusted score differences (95% confidence interval) for PCS and mental MCS scores by number of comorbid conditions among type 2 diabetic patients (n = 912)

PCS = physical component summary; MCS = mental component summary.

a Adjusted for age, sex, duration of diabetes, body mass index, and insulin use.

Quality of life related to clinical characteristics

The PCS and MCS scores with respect to clinical characteristics are presented in Table 3. The presence of comorbid conditions was associated with lower scores of PCS and MCS (P < 0.001). The mean duration of diabetes for respondents was 7.1 (SD: 5.8) years. The PCS was lower in patients with a duration of disease >5 years (31.2 ± 14) than in patients having a duration of disease <5 years (34.4 ± 13.1). In contrast, no statistically significant difference was found on the MCS related to duration of disease. T2DM patients taking insulin injection had a significantly lower MCS score (44.0 ± 10) than those not taking insulin injection (48.1 ± 8.9). The mean BMI was 26.0 kg/m2 (SD: 4.9), and the higher the BMI the poorer the score of both PCS and MCS.

Table 3. Descriptive statistics of health-related quality of life scores, PCS-12, and MCS-12 by clinical characteristics

PCS-12 = physical component summary; MCS-12 = mental component summary.

Quality of life related to type of comorbidity

Most comorbid conditions were associated with decreased physical HRQL, with the exception of deafness/auditory impairment, epilepsy, depression, and cancer. Stroke had highest negative impact on physical HRQL with a mean difference of 11.9, followed by visual impairment (5.6), chronic lung disease (5.9), chronic kidney disease (5.5), heart disease (5.5), and APD (5.4). Most comorbid conditions were also associated with decreased mental HRQL but the differences were small. Only depression showed a clinically relevant negative impact on MCS, with a mean difference score of 6.8. (Table 4)

Table 4. Mean differences in PCS and MCS scores between type 2 diabetic patients with and without the comorbid condition

PCS = physical component summary; MCS = mental component summary.

Clinically relevant mean differences, defined as ≥5, are presented in bold.

* Statistically significant with P < 0.05.

Discussion

Diabetes mellitus is known to be associated with reduced HRQL due to its chronicity and complications. In this context, the findings of the present study are important as it explores the impact of various patient characteristics and comorbid conditions on both physical and mental components of HRQL among type 2 diabetic patients attending primary care. This study found that the presence of comorbidity affected the PCS and MCS significantly among diabetic patients. Previous studies have also concluded that quality of life among diabetic patients with comorbid conditions is lower than individuals with only diabetes (Maddigan et al., Reference Maddigan, Feeny and Johnson2005).

An important finding is the significant association of the comorbidity count with the HRQL. With the increase in number of comorbid conditions, there was a considerable reduction of both components of HRQL showing that a dose–response relationship is likely. Like past studies, our study has also reinforced that there is greater deterioration of the physical component compared to the mental component with the rise in number of comorbidities (Jasani et al., Reference Jasani, Piterman and McCall1999; Fortin et al., Reference Fortin, Bravo, Hudon, Lapointe, Almirall, Dubois and Vanasse2006; Wang et al., Reference Wang, Beyer, Gensichen and Gerlach2008).

Among comorbid conditions studied, hypertension was the most prevalent condition. The differences of PCS and MCS scores with patients without hypertension were low and statistically significant but were not clinically relevant. A possible explanation could be the asymptomatic nature of hypertension. Similar findings have also been reported by other studies (Stewart et al., Reference Stewart, Greenfield, Hays, Wells, Rogers, Berry, McGlynn and Ware1989; Wood et al., Reference Wood, Maton and Sorensen1998).

In our study, we found a substantial impact of stroke on both PCS and MCS. Stroke or cerebrovascular attack is for the most part of a debilitating disease. Multiple studies also concluded the reduced quality of life associated with stroke (Sprangers et al., Reference Sprangers, de Regt, Andries, van Agt, Bijl, de Boer, Foets, Hoeymans, Jacobs, Kempen and Miedema2000; Oliva et al., Reference Oliva, Fernández-Bolaños and Hidalgo2012).

APD was significantly associated with lower PCS and MCS, similar to prior studies. Earlier studies have stated that aggravation of symptoms such as heartburn with simple physical activities like bending forward or moderate housework negatively influences the physical component scores (Jasani et al., Reference Jasani, Piterman and McCall1999; Alonso et al., Reference Alonso, Ferrer, Gandek, Ware, Aaronson, Mosconi, Rasmussen, Bullinger, Fukuhara, Kaasa and Leplège2004).

Visual and auditory impairment had a high impact on HRQL due to limitation to mobility and daily activities. Our study confirmed that visual impairment affects the physical component of HRQL. The impact of auditory impairment and deafness on physical component of HRQL was not statistically significant in our study, which may be due to the low number of diabetic patients with this comorbidity limiting the power of the study. Previous studies also concluded that sensory impairment has a negative influence on activities of daily living and considerably affects HRQL (Langelaan et al., Reference Langelaan, de Boer, van Nispen, Wouters, Moll and van Rens2007).

Musculoskeletal disorders like chronic back ache and arthritis were associated with poor HRQL. However, contrary to previous studies, the mean score differences in our study were not clinically relevant. A significant and clinically relevant association was found between chronic lung disorders and PCS, similar to the conclusions from previous studies (Ketelaars et al., Reference Ketelaars, Schlösser, Mostert, Abu-Saad, Halfens and Wouters1996; Eisner et al., Reference Eisner, Blanc, Yelin, Sidney, Katz, Ackerson, Lathon, Tolstykh, Omachi, Byl and Iribarren2008 ; Stridsman et al., Reference Stridsman, Zingmark, Lindberg and Skär2015). The reduced HRQL scores in patients with chronic kidney disease and heart disease are also consistent with findings from previous studies (Yong et al., Reference Yong, Kwok, Wong, Suen, Chen and Tse2009; Soni et al., Reference Soni, Weisbord and Unruh2010; y Pena et al., Reference y Pena, Barrera, Cordero, de Miguel, Perez, Lopez-de Andres and Jiménez-García2010)

Obesity was not considered as comorbidity in this study as it is strongly related to diabetes mellitus. As in past studies, HRQL among diabetic patients with obesity was lower than in diabetic patients with normal weight (Wong et al., Reference Wong, Lo, Wong and Fung2013), but the difference was not found to be clinically relevant in our study. A possible explanation could be the coexistence of other comorbidities with higher impact on HRQL.

Consistent with prior findings (Zurita-Cruz et al., Reference Zurita-Cruz, Manuel-Apolinar, Arellano-Flores, Gutierrez-Gonzalez, Najera-Ahumada and Cisneros-González2018), diabetic patients with depression had poor MCS scores, but depression did not affect the PCS. Other mental conditions than depression were not included in our study.

Strength and limitations

This is the first study to assess the impact of comorbidity on HRQL among type 2 diabetic patients in urban primary care settings in India. As it is a primary care facility study, the findings can be fairly generalized. The robust sample size of our study is another strength. A wide range of comorbidities, including concordant and discordant comorbidities, have been taken into account for studying the impact. The findings of our study can act as a base for future longitudinal studies to explore in greater detail the impact of comorbid conditions on HRQL among T2DM patients.

As a cross-sectional study, the lack of causality and effect explanation is its major limitation. The issues of reliability and validity with self-reported comorbidity are another limitation of our study. HRQL is a subjective issue, and as this is a point-in-time study, it is possible that if the respondents were interviewed at other times, there may be variation in responses. Lack of data on the severity of comorbid conditions is also a limitation as the severity of a condition plays an important role in the HRQL. Age and duration of disease may be considered as proxy measures for severity for which we did adjusted analyses.

Policy implications

The present study calls attention to the adverse impact of comorbid conditions on HRQL among diabetic patients. It reiterates the need for focused and comprehensive care for chronic conditions especially diabetes mellitus, which is associated with multiple complications and comorbidities. As accessible and affordable first level of care, primary health centers (PHCs) are ideally placed for management of multiple chronic conditions. However, in LMICs like India where most of the PHCs are ill-equipped, the chronic disease care is generally fragmented and adds to the burden of chronic disease patients. The recent ‘Health and Wellness Centre’ (HWC) initiative of Government of India, wherein existing PHCs shall be strengthened with facilities for comprehensive primary care to improve community access, is a step forward in the direction of continuity of care (NHSRC, 2018). However, other than screening and prevention programs, that is, existing National Programme for the Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke, due emphasis should also be placed on the curative and rehabilitative aspects of the chronic conditions. As concluded in our study, diabetic patients with visual impairment and stroke have significantly reduced quality of life, hence more emphasis may be given to the rehabilitation of the sequelae of these diseases to reduce the burden and improve quality of life and health outcomes. The provision of physiotherapist at PHCs under HWC initiative is a welcome step in this regard. MH counselors can play a significant role in addressing depression related to chronic conditions among these patients. Hence, we recommend the integration of National Mental Health Programme components for primary care with the HWC initiative that will help in improving the quality of life and health outcomes among diabetic patients.

Acknowledgments

The authors are grateful to the Department of Health and Family Welfare, Government of Odisha for their kind cooperation.

Financial Support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Conflicts of Interest

None.

Ethical approval and consent to participate

All procedures performed were in accordance with the ethical standards of the national and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Odisha state research and ethics committee gave the ethical approval for the study (letter no. 161/SHRMU dt. 16.05.2014). Respondents were informed about the purpose of the study and the information assessed. We collected their signature or thumb impression on the informed consent form. The data were coded and the identities of the respondents were kept confidential.

Authors contribution

SP and FS designed the study. SP, SJ, SP contributed to data collection and analysis. All the authors contributed to the drafting of manuscript and approved the final version for publication.

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/S1463423620000055.

References

Adriaanse, MC, Drewes, HW, van der Heide, I, Struijs, JN and Baan, CA (2016) The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Quality of Life Research 25, 175182.CrossRefGoogle ScholarPubMed
Agborsangaya, CB, Lau, D, Lahtinen, M, Cooke, T and Johnson, JA (2013) Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Quality of Life Research 22, 791799.CrossRefGoogle ScholarPubMed
Alonso, J, Ferrer, M, Gandek, B, Ware, JE, Aaronson, NK, Mosconi, P, Rasmussen, NK, Bullinger, M, Fukuhara, S, Kaasa, S and Leplège, A (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research 13, 283298.CrossRefGoogle ScholarPubMed
Anon (2015) Census 2011 India. Retrieved 30 March 2019 from https://www.census2011.co.in/census/city/270-bhubaneswar.htmlGoogle Scholar
Eisner, MD, Blanc, PD, Yelin, EH, Sidney, S, Katz, PP, Ackerson, L, Lathon, P, Tolstykh, I, Omachi, T, Byl, N and Iribarren, C (2008) COPD as a systemic disease: impact on physical functional limitations. The American Journal of Medicine 121, 789796.CrossRefGoogle ScholarPubMed
Fortin, M, Bravo, G, Hudon, C, Lapointe, L, Almirall, J, Dubois, MF and Vanasse, A (2006) Relationship between multimorbidity and health-related quality of life of patients in primary care. Quality of Life Research 15, 8391.CrossRefGoogle ScholarPubMed
IASO (2000) World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Retrieved 20 April 2019 from http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdfGoogle Scholar
Janus, ED, Wat, NMS, Lam, KSL, Cockram, CS, Siu, STS, Liu, LJ, Lam, TH and Hong Kong Cardiovascular Risk Factor Steering Committee (2000) The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Diabetic Medicine 17, 741745.CrossRefGoogle Scholar
Jasani, K, Piterman, L and McCall, L (1999) Gastroesophageal reflux and quality of life. Patient’s knowledge, attitudes and perceptions. Australian Family Physician 28, S15S18.Google Scholar
Javanbakht, M, Abolhasani, F, Mashayekhi, A and Baradaran, HR (2012) Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey. PLoS One 7, e44526.CrossRefGoogle ScholarPubMed
Ketelaars, CA, Schlösser, MA, Mostert, R, Abu-Saad, HH, Halfens, RJ and Wouters, EF (1996) Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 51, 3943.CrossRefGoogle ScholarPubMed
Kung, AWC, Janus, ED and Lau, CP (1996) The prevalence of diabetes mellitus and its effect in elderly subjects in Hong Kong. Hong Kong Medical Journal 2, 2633.Google Scholar
Lam, CL, Eileen, YY and Gandek, B (2005) Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of Life Research 14, 539547.CrossRefGoogle ScholarPubMed
Langelaan, M, de Boer, MR, van Nispen, RM, Wouters, B, Moll, AC and van Rens, GH (2007) Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiology 14, 119126.CrossRefGoogle ScholarPubMed
Maddigan, SL, Feeny, DH and Johnson, JA (2005) Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Quality of Life Research 14, 13111320.CrossRefGoogle Scholar
Néss, S, Midthjell, K, Moum, T, Sørensen, T and Tambs, K (1995) Diabetes mellitus and psychological well-being. Results of the Nord-Trøndelag health survey. Scandinavian Journal of Social Medicine 23, 179188.CrossRefGoogle Scholar
NHSRC (2018) AYUSHMAN BHARAT: Comprehensive Primary Health Care through Health and Wellness Centers. Retrieved 20 April 2019 from http://nhsrcindia.org/sites/default/files/Operational%20Guidelines%20For%20Comprehensive%20Primary%20Health%20Care%20through%20Health%20and%20Wellness%20Centers.pdfGoogle Scholar
Oliva, J, Fernández-Bolaños, A and Hidalgo, Á (2012) Health-related quality of life in diabetic people with different vascular risk. BMC Public Health 12, 812.CrossRefGoogle ScholarPubMed
Patel, B, Oza, B, Patel, K, Malhotra, S and Patel, V (2014) Health related quality of life in type-2 diabetic patients in Western India using World Health Organization Quality of Life–BREF and appraisal of diabetes scale. International Journal of Diabetes in Developing Countries 34, 100107.CrossRefGoogle Scholar
Pati, S, Hussain, MA, Swain, S, Salisbury, C, Metsemakers, JF, Knottnerus, JA and Akker, MVD (2016) Development and validation of a questionnaire to assess multimorbidity in primary care: An Indian experience. BioMed Research International 2016, 9.CrossRefGoogle Scholar
Pati, S and Schellevis, FG (2017) Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India). PLoS One 12, e0181661.CrossRefGoogle Scholar
Rubin, RR and Peyrot, M (1999) Quality of life and diabetes. Diabetes/Metabolism Research and Reviews 15, 205218.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Saleh, F, Ara, F, Mumu, SJ and Hafez, MA (2015) Assessment of health-related quality of life of Bangladeshi patients with type 2 diabetes using the EQ-5D: a cross-sectional study. BMC Research Notes 8, 497.CrossRefGoogle ScholarPubMed
Shim, YT, Lee, J, Toh, MPHS, Tang, WE and Ko, Y (2012) Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore. Diabetic Medicine 29, e241e248.CrossRefGoogle ScholarPubMed
Soni, RK, Weisbord, SD and Unruh, ML (2010) Health-related quality of life outcomes in chronic kidney disease. Current Opinion in Nephrology and Hypertension 19, 153.CrossRefGoogle ScholarPubMed
Sprangers, MA, de Regt, EB, Andries, F, van Agt, HM, Bijl, RV, de Boer, JB, Foets, M, Hoeymans, N, Jacobs, AE, Kempen, GI and Miedema, HS (2000) Which chronic conditions are associated with better or poorer quality of life? Journal of Clinical Epidemiology 53, 895907.CrossRefGoogle ScholarPubMed
Stewart, AL, Greenfield, S, Hays, RD, Wells, K, Rogers, WH, Berry, SD, McGlynn, EA and Ware, JE (1989) Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 262, 907913.CrossRefGoogle ScholarPubMed
Stridsman, C, Zingmark, K, Lindberg, A and Skär, L (2015) Creating a balance between breathing and viability: experiences of well-being when living with chronic obstructive pulmonary disease. Primary Health Care Research & Development 16, 4252.CrossRefGoogle ScholarPubMed
Struijs, JN, Baan, CA, Schellevis, FG, Westert, GP and Van Den Bos, GA (2006) Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Services Research 6, 84.CrossRefGoogle ScholarPubMed
Sundararaman, T, Muraleedharan, VR and Mukhopadhyay, I (2016) NSSO 71st round data on health and beyond. Economic & Political Weekly 51, 85.Google Scholar
Wang, HM, Beyer, M, Gensichen, J and Gerlach, FM (2008) Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey. BMC Public Health 8, 246.CrossRefGoogle ScholarPubMed
Ware, JE, Keller, SD and Kosinski, M (1995) SF-12: How to score the SF-12 physical and mental health summary scales. Boston, MA Health Institute, New England Medical Center.Google Scholar
Wee, HL, Cheung, YB, Li, SC, Fong, KY and Thumboo, J (2005) The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health and Quality of Life Outcomes 3, 2.CrossRefGoogle Scholar
Wexler, DJ, Grant, RW, Wittenberg, E, Bosch, JL, Cagliero, E, Delahanty, L, Blais, MA and Meigs, JB (2006) Correlates of health-related quality of life in type 2 diabetes. Diabetologia 49, 14891497.CrossRefGoogle ScholarPubMed
Wong, CK, Lo, YY, Wong, WH and Fung, CS (2013) The associations of body mass index with physical and mental aspects of health-related quality of life in Chinese patients with type 2 diabetes mellitus: results from a cross-sectional survey. Health and Quality of Life Outcomes 11, 142.CrossRefGoogle ScholarPubMed
Wood, M, Maton, PN and Sorensen, S (1998) The impact of gastroesophageal reflux disease on health-related quality of life. The American Journal of Medicine 104, 252258.Google Scholar
y Pena, ME, Barrera, VH, Cordero, XF, de Miguel, AG, Perez, MR, Lopez-de Andres, A and Jiménez-García, R (2010) Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area. Diabetes & Metabolism 36, 305311.CrossRefGoogle Scholar
Yong, DSP, Kwok, AOL, Wong, DML, Suen, MHP, Chen, WT and Tse, DMW (2009) Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliative Medicine 23, 111119.CrossRefGoogle ScholarPubMed
Zurita-Cruz, JN, Manuel-Apolinar, L, Arellano-Flores, ML, Gutierrez-Gonzalez, A, Najera-Ahumada, AG and Cisneros-González, N (2018) Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health and Quality of Life Outcomes 16, 94.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Basic characteristics of type 2 diabetic patients by comorbidity status

Figure 1

Figure 1. Number of comorbidities across sex.

Figure 2

Figure 2. Chronic comorbidities.

Figure 3

Table 2. Mean scores with SD, unadjusted and adjusted score differences (95% confidence interval) for PCS and mental MCS scores by number of comorbid conditions among type 2 diabetic patients (n = 912)

Figure 4

Table 3. Descriptive statistics of health-related quality of life scores, PCS-12, and MCS-12 by clinical characteristics

Figure 5

Table 4. Mean differences in PCS and MCS scores between type 2 diabetic patients with and without the comorbid condition

Supplementary material: PDF

Pati et al. supplementary material

Pati et al. supplementary material

Download Pati et al. supplementary material(PDF)
PDF 341.3 KB